Docoh
Loading...

AUPH Aurinia Pharmaceuticals

APP
Utility
Ophthalmic Compositions
4 Nov 21
The embodiments disclosed herein relate to ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors, and more particularly to methods for treating an ocular disease and/or condition using the disclosed compositions.
Ashim K. MITRA, Poonam R. VELAGALETI, Subramanian NATESAN
Filed: 12 Apr 21
GRANT
Utility
Ophthalmic compositions
13 Apr 21
The embodiments disclosed herein relate to ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors, and more particularly to methods for treating an ocular disease and/or condition using the disclosed compositions.
Ashim K. Mitra, Poonam R. Velagaleti, Subramanian Natesan
Filed: 8 Feb 19
GRANT
Reissue
Cyclosporine analogue mixtures and their use as immunomodulating agents
28 Sep 20
The invention is directed to isomeric mixtures of cyclosporine analogues that are structurally similar to cyclosporine A.
Selvaraj A. Naicker, Randall W Yatscoff, Robert T Foster
Filed: 29 Jun 14
APP
Utility
Ophthalmic Compositions
8 Jan 20
The embodiments disclosed herein relate to ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors, and more particularly to methods for treating an ocular disease and/or condition using the disclosed compositions.
Ashim K. Mitra, Poonam R. Velagaleti, Subramanian Natesan
Filed: 7 Feb 19
GRANT
Utility
Cyclosporine analogue mixtures and their use as immunomodulating agents
11 Nov 19
The invention is directed to isomeric mixtures of cyclosporine analogues that are structurally similar to cyclosporine A.
Selvaraj A. Naicker, Randall W Yatscoff, Robert T Foster
Filed: 13 Aug 17
  • 1
Patents are sorted by USPTO publication date, most recent first